Pacific Biosciences Of California (PACB) Share-based Compensation (QoQ) (2010 - 2026)
Pacific Biosciences Of California (PACB) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 389.87 Mn | 153.00 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 107.74% |
| Mar 31, 2026 | -53.49% |
| Dec 31, 2025 | -12.71% |
| Sep 30, 2025 | 229.54% |
| Jun 30, 2025 | -128.67% |
| Mar 31, 2025 | -58.37% |
| Dec 31, 2024 | 293.33% |
| Sep 30, 2024 | -313.39% |
| Jun 30, 2024 | -11.81% |
| Mar 31, 2024 | 17.73% |
| Dec 31, 2023 | -15.78% |
| Sep 30, 2023 | 10.06% |
| Jun 30, 2023 | -0.34% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | 406.77% |
| Sep 30, 2022 | 317.81% |
| Jun 30, 2022 | -96.26% |
| Mar 31, 2022 | -47.49% |
| Dec 31, 2021 | 128.75% |
| Sep 20, 2021 | 19.58% |